Windlas Biotech Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
800.00 -1.30 (-0.16%)Updated : 10 Apr 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 693.38566.23465.22425.65
Other Net 0.510.370.42-0.05
Diluted Weighted Average Shares 2.112.092.162.05
Gain( Loss)on Saleof Assets 0.010.010.880.01
Depreciation/ Amortization 27.9913.4412.3612.15
Operating Income 66.4964.7347.8640.28
Net Income 60.9958.1942.6338.09
Income Availableto Com Excl Extra Ord 60.9958.1942.6338.09
Other Operating Expenses Total 2.442.571.892.10
Net Income Before Taxes 79.7677.0957.0445.57
Minority Interest 0.000.000.000.00
Net Income After Taxes 60.9958.1942.6338.09
Income Availableto Com Incl Extra Ord 60.9958.1942.6338.09
Costof Revenue Total 493.47412.33338.35313.83
Gross Profit 266.41218.63174.73152.10
Interest Inc( Exp) Net- Non- Op Total 12.7511.997.885.33
Diluted Net Income 60.9958.1942.6338.09
DPS- Common Stock Primary Issue 5.805.504.003.50
Provisionfor Income Taxes 18.7618.9014.417.48
period Type ----
Net Income Before Extra Items 60.9958.1942.6338.09
Total Revenue 759.88630.96513.08465.93
period Length 12.0012.0012.0012.00
Revenue 759.88630.96513.08465.93
Selling/ General/ Admin Expenses Total 163.24130.01103.6691.07
Diluted Normalized EPS 28.8727.8719.4018.58
Research Development 6.257.888.956.51
Diluted EPS Excluding Extra Ord Items 28.8727.8819.7018.58
Unusual Expense( Income) -0.000.010.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,414.00+23.00(1.65%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)